Akromegalili olguda gelişen postoperatif ciddi hipertansiyon

Akromegali, hipofiz adenomuna bağlı büyüme hormonu aşırı salınımı ve yükselmiş insülin benzeri büyüme faktörü-1 (IGF-1) ile karakterize olan bir hastalıktır. Bu hastalarda hipertansiyon %18-60 olguda görülüp yaşla birlikte artmaktadır ve diyastolik kan basıncında artış ön plandadır. Artan plazma hacmi, ANP düzeylerinde azalma, insülin direnci ve hastalık süresi, hipertansiyon riskini artıran eşlik eden faktörler hipertansiyona neden olur.  muhtemeldir. Bu makalede pitüiter mikroadenoma sekonder akromegali bulunan bir kadın olguda postoperatif ciddi hipertansiyon tablosu sunulmuştur..

Postoperative severe hypertension in a patient with acromegaly

Acromegaly is a chronic disorder characterized by excessive secretion of growth hormone and elevated insulin-like growth factor-1 levels, usually due to a pituitary adenoma. In this patients, hypertension occurs in 18-60%, with a predominance of diastolic blood pressure elevation that increases in prevalence with age. Hypertension is likely due to increased plasma volume, to decreased ANP levels and to insulin resistance and disease duration are coexisting factors likely to increase the risk of hypertension. In this article, we report a case of a female patient with postoperative severe hypertension who presented with acromegaly secondary to a pituitary microadenoma.

___

  • 1. Kraatz C, Benker G, Weber F, Lüdecke D, Hirche H, Reinwein D. Acromegaly and hypertension: Prevalence and relationship to the renin-angiotensinaldosterone system. Klin Wochenschr. 1990;68:583- 7.
  • 2. Bondanelli M, Ambrosio MR, degli Uberti EC. Pathogenesis and prevalence of hypertension in acromegaly. Pituitary. 2001;4:239-49.
  • 3. Minniti G, Moroni C, Jaffrain-Rea ML, et al. Prevalance of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring. Clin Endocrinol. 1998;48:149-52
  • 4. Fedrizzi D, Rodrigues TC, Costenaro F, Scalco R, Czepielewski MA. Hypertension-related factors in patients with active and inactive acromegaly. Arq Bras Endocrinol Metabol. 2011;55:468-74
  • 5. Kamenicky P, Viengchareun S, Blanchard A, Meduri G, Zizzari P, Imbert-Teboul M et al. Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology. 2008;149:3294–305.
  • 6. Colao A, Spiezia S, Cerbone G, Pivonello R, Marzullo P, Ferone D et al. Increased arterial intimamedia thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin Endocrinol (Oxf). 2001;54:515-24.
  • 7. Akgul E, Tokgozoglu SL, Erbas T, Kabakci G, Aytemir K, Haznedaroglu I et al. Evaluation of the impact of treatment on endothelial function and cardiac performance in acromegaly. Echocardiography. 2010;27:990-6
  • 8. Cafiero T, Cavallo LM, Frangiosa A, Burrelli R, Gargiulo G, Cappabianca P et al. Clinical comparison of remifentanil–sevoflurane vs. remifentanil– propofol for endoscopic endonasal transphenoidal surgery. Eur J Anaesthesiol. 2007; 24:441-6.
  • 9. Asouhidou I, Trikoupi A. Esmolol reduces anesthetic requirements thereby facilitating early extubation; a prospective controlled study in patients undergoing intracranial surgery. BMC Anesthesiol. 2015;15:172.
  • 10. Kim SH, Stoicea N, Soghomonyan S, Bergese SD. Remifentanil-acute opioid tolerance and opioidinduced hyperalgesia: a systematic review. Am J Ther. 2015;22:e62-74.
  • 11. Nemergut EC, Zuo Z, Jane JA, Laws ER. Diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg. 2005;103:448–54.
Cukurova Medical Journal-Cover
  • ISSN: 2602-3032
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1976
  • Yayıncı: Çukurova Üniversitesi Tıp Fakültesi